Orforglipron is poised to make a significant impact in the realm of diabetes management and weight loss medication.Developed by Eli Lilly, this innovative oral drug utilizes the GLP-1 hormone to regulate blood sugar levels while promoting weight loss—an exciting alternative to existing therapies primarily delivered by injection.